Tirzepatide is a prescription drug that was first developed to help patients with type 2 diabetes regulate their blood sugar, but it is also approved by the FDA for use with weight management
The body undergoes adjustments in metabolism, appetite, and digestion, which can initially drain energy
A: Weight gain is a symptom of menopause experienced by 60%70% of midlife women and people assigned female at birth
It works primarily by suppressing appetite, slowing gastric emptying, and increasing energy expenditure
Identifying these risks with your doctor allows for a tailored treatment plan, ensuring your specific health needs are met while on semaglutide
Other Ingredients: Hydroxypropyl methylcellulose (vegetable capsule), magnesium oxide (buffering agent), magnesium stearate, silicon dioxide